Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Published on 13/10/202513/10/2025 by Research Hypothesis

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award | Radiologist | University Hospital Quironsalud Madrid | Spain

Assoc. Prof. Dr. Mar Jimenez de la Pena is a highly accomplished radiologist and academician with a distinguished career devoted to advancing diagnostic imaging, neuroimaging, and translational radiology. She completed her Licentiate in Medicine and Surgery at the Universidad Complutense de Madrid and specialized in Radiodiagnosis at Hospital 12 de Octubre in Madrid, establishing a robust clinical and scientific foundation. Currently serving as the Associate Head of Diagnostic Imaging at Hospital Universitario QuirónSalud Madrid, she also contributes as a Professor of Medicine at the Universidad Europea de Madrid, where she mentors medical students and radiology residents. Her professional experience spans more than two decades, encompassing academic instruction, clinical excellence, and leadership in medical imaging. Assoc. Prof. Dr. Mar Jimenez de la Pena has been actively engaged in national and international research collaborations, focusing on the application of advanced MRI techniques in neurological disorders, pediatric neuroimaging, and genetic syndromes. Her research interests center on neurodevelopmental disorders, brain perfusion analysis, and the application of artificial intelligence in MRI interpretation. She has demonstrated outstanding research skills in multimodal MRI data acquisition, neuroimage analysis, and clinical study design. Her work has been published in top-tier journals such as Frontiers in Neuroscience, Neuroradiology, European Journal of Medical Genetics, and American Journal of Medical Genetics Part A, significantly contributing to the understanding of complex neuroimaging patterns and clinical correlations. With over 40 peer-reviewed articles, including 33 international papers, and multiple book chapters, she has established a strong academic footprint. Assoc. Prof. Dr. Mar Jimenez de la Pena has received over 30 prestigious awards, including 29 honors from the Spanish Society of Radiology (SERAM), recognition from the Spanish Society of Neurosurgery (SENR), and an American Society of Radiology Award for her scientific presentations. Her memberships in SERAM, SENR, and ESR, alongside her role as a reviewer for Radiología, underscore her professional dedication to the advancement of radiological science. A visionary researcher and educator, she continues to contribute to training programs for medical imaging professionals, fostering innovation and excellence in radiological education. In conclusion, Assoc. Prof. Dr. Mar Jimenez de la Pena exemplifies a perfect blend of clinical expertise, academic leadership, and research innovation, making her a highly deserving candidate for international recognition in medical imaging and radiological research. Her continued contributions promise to shape the future of neuroimaging and radiodiagnostic excellence globally.

Profile: ORCID

Featured Publications

Jimenez de la Pena, M. (2023). Tatton‐Brown–Rahman syndrome: Novel pathogenic variants and new neuroimaging findings. American Journal of Medical Genetics Part A. Citations: 12
Jimenez de la Pena, M. (2023). White-matter lesions and cortical cerebral blood flow evaluation by 3D arterial spin-labeled perfusion MRI in asymptomatic divers: Correlation with patent foramen ovale occurrence. Journal of Clinical Medicine. Citations: 18
Jimenez de la Pena, M. (2022). Development of a super-resolution scheme for pediatric magnetic resonance brain imaging through convolutional neural networks. Frontiers in Neuroscience. Citations: 25
Jimenez de la Pena, M. (2022). Mutations in the COL18A1 gene associated with Knobloch syndrome and structural brain anomalies: A novel case report and literature review of neuroimaging findings. Neurocase. Citations: 9
Jimenez de la Pena, M. (2021). Neuroimaging findings in patients with EBF3 mutations: Report of two cases. Molecular Syndromology. Citations: 7
Jimenez de la Pena, M. (2021). Abnormal frontal gyrification pattern and uncinate development in patients with KBG syndrome caused by ANKRD11 aberrations. European Journal of Paediatric Neurology. Citations: 15
Jimenez de la Pena, M. (2020). Automatic identification of atypical clinical fMRI results. Neuroradiology. Citations: 22

Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Published on 20/08/202520/08/2025 by Research Hypothesis

Assoc. Prof. Dr . Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Christina Pettan-Brewer | Medicine and Health Sciences | Associate Professor and Director | School of Medicine University of Washington | United States

Associate Professor Dr. Christina Pettan-Brewer is a distinguished veterinary scientist and global health leader whose career bridges research, education, and international policy. With advanced training in veterinary medicine, genetics, epidemiology, and One Health, she has contributed significantly to understanding zoonotic diseases, environmental health, and the genetic and molecular mechanisms of aging and disease. She serves as a key advisor and expert for international organizations including UNEP Nature for Health, WHO, PREZODE, and the International Alliance against Health Risks in Wildlife Trade, demonstrating her influence on global health strategies and pandemic prevention platforms. As Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health, she plays a pivotal role in advancing interdisciplinary scientific communication. Multilingual and internationally engaged, she combines her academic role at the University of Washington with mentorship, Fulbright program leadership, and advocacy for underrepresented groups in science, making her a recognized authority in One Health, planetary health, and global public health innovation.

Professional Profile

Scopus Profile

Education

Associate Professor Dr. Christina Pettan-Brewer has a strong and diverse educational background that reflects her interdisciplinary expertise. She began her academic journey in Brazil, earning a technical degree in Zoology and Clinical Pathology, followed by a Doctor of Veterinary Medicine with honors from the Universidade Federal de Viçosa. She then pursued advanced studies in the United States at the University of California, Davis, completing a Master of Science in Wildlife and Zoological Medicine and Comparative Pathology while also receiving accreditation as a Doctor of Veterinary Medicine. To further strengthen her expertise in global health, she obtained a PhD in One Health and Global Health from the Federal University of Paraná in collaboration with the University of Colorado, specializing in Indigenous Health and Emerging Infectious Diseases. Her educational achievements, marked by honors and top performance, form the foundation of her career in veterinary medicine, public health, genetics, and planetary health.

Professional Experience

Associate Professor Dr. Christina Pettan-Brewer has built an impressive professional career that integrates academic leadership, research, and international advisory roles. She began her faculty journey as an Assistant Professor at Centenary University in New Jersey, where she developed curricula for pre-veterinary and pre-medicine programs while conducting research on avian pathology during the West Nile Virus outbreak. At the University of Washington School of Medicine, she has advanced through roles as Acting Instructor, Acting Assistant Professor, and now Associate Professor in the Department of Comparative Medicine, contributing extensively to research in genetics, zoonotic diseases, and One Health. Beyond academia, she has served as a senior advisor and technical expert for global organizations such as UNEP, WHO, PREZODE, and international veterinary associations, shaping global health strategies and pandemic preparedness. Her editorial leadership with CABI One Health and Beyond One Ocean Health further demonstrates her influence in scientific communication, while her Fulbright program advisory role highlights her dedication to mentoring and international academic exchange.

Research Interest

Associate Professor Dr. Christina Pettan-Brewer’s research interests lie at the intersection of veterinary medicine, public health, and planetary health, with a strong emphasis on the One Health approach. She focuses on zoonotic and emerging infectious diseases, pandemic prevention, and the interconnectedness of human, animal, and environmental health. Her work extends to the genetic and molecular mechanisms of aging, chronic diseases, and susceptibility to toxins, as well as the health impacts of climate change and biodiversity loss. She is particularly interested in Indigenous health, global health equity, and the role of wildlife and ecosystem preservation in preventing future pandemics. Through her interdisciplinary research, she seeks to advance collaborative solutions that strengthen global health systems, protect vulnerable populations, and promote sustainable, resilient communities

Award and Honor

Associate Professor Dr. Christina Pettan-Brewer has been recognized with numerous honors and prestigious appointments that highlight her global leadership in One Health and public health. She has served as a United Nations Environment Programme (UNEP) One Health Expert and Technical Advisory Group member for the Nature for Health initiative, representing Latin America and later co-chairing its expert committee. Her expertise has been sought by the World Health Organization’s Global Preparedness Monitoring Board, PREZODE’s International Data Working Group, and the Agence Nationale de la Recherche in France for evaluating pandemic prevention strategies. She has also been appointed as a Fulbright Program Adviser, National Scholar Program Ambassador, and Reviewer, reflecting her commitment to international education and research exchange. In addition, her editorial leadership roles as Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health stand as significant honors that demonstrate her influence in shaping global scientific dialogue. These achievements collectively underscore her distinguished reputation as a trusted advisor, scholar, and thought leader in global health.

Publications Top Noted

Effects of Covid-19 Pandemic in the Surveillance and Control of Neglected Tropical Diseases and Malaria: A Systematic Review

Year: 2025

Protecting Urban Wildlife Fauna, Fighting Zoonoses, and Preventing Biophobia in Brazil

Year: 2025

Conclusion

Dr. Christina Pettan-Brewer is a highly suitable candidate for the Best Researcher Award. Her career exemplifies global leadership, interdisciplinary research, and a strong commitment to advancing One Health, pandemic prevention, and planetary health. With a proven record of academic excellence, international collaboration, and impactful advisory roles, she stands out as a researcher whose work bridges science, policy, and education. Addressing minor improvements related to visibility of individual research outputs would further strengthen her profile, but her broad and meaningful contributions make her a compelling and deserving nominee for this recognition.

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Published on 08/08/202508/08/2025 by Research Hypothesis

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile

Scopus Profile

Education

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.

Maria Kontaridis | Medicine and Health Sciences | Best Researcher Award

Published on 10/07/202510/07/2025 by Research Hypothesis

Dr. Maria Kontaridis | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Executive Director at Masonic Medical Research Institute, United States

Dr. Maria Irene Kontaridis is a distinguished biomedical scientist and academic leader with an extensive background in cardiovascular research, molecular pharmacology, and translational medicine. She holds dual undergraduate degrees from the University of Florida and advanced degrees, including a Ph.D. in Biological and Biomedical Sciences from Yale University, where she also completed a Mini MBA. Her postdoctoral training at Yale and Harvard laid the foundation for a prolific career marked by influential faculty appointments at Harvard Medical School and Beth Israel Deaconess Medical Center. Currently serving as Executive Director and Gordon K. Moe Professor at the Masonic Medical Research Institute, she oversees strategic research initiatives, institutional growth, and scientific innovation. Dr. Kontaridis has led major national and international symposia, contributed to scientific and community development efforts, and is an advocate for women in science and academic leadership. Her interdisciplinary expertise, combined with her administrative acumen and philanthropic outreach, has positioned her as a transformative figure in biomedical research and academic medicine.

Professional Profile

🎓 Education of Dr. Maria Kontaridis

Dr. Maria Kontaridis has an exceptional academic foundation marked by interdisciplinary excellence. She earned two undergraduate degrees in 1995 from the University of Florida—a B.S. in Chemistry (Cum Laude) with a Minor in Business Administration, and a B.A. in Classical Studies (Summa Cum Laude). She pursued advanced scientific training at Yale University, completing a Master of Science (M.S.) in Pharmacology and Molecular Medicine in 1998, followed by an M.Phil. in 1999, and a Ph.D. in Biological and Biomedical Sciences in 2002 under the mentorship of Dr. Anton Bennett. Further enhancing her academic versatility, she obtained a Mini Master of Business Administration Certificate from Yale in 2000. In recognition of her scientific achievements and leadership, she was awarded an honorary Doctor of Science (D.Sc. h.c.) in 2025 by SUNY Polytechnic Institute, solidifying her stature as a leader in biomedical education and research.

💼 Professional Experience of Dr. Maria Kontaridis

Dr. Maria Kontaridis has built a distinguished career in biomedical research, academic leadership, and institutional development. She began her professional journey with postdoctoral fellowships at Yale University and Harvard Medical School, focusing on pharmacology and hematology/oncology under the mentorship of esteemed scientists. Her academic appointments include progressive faculty roles at Harvard Medical School, where she served as Instructor, Assistant Professor, and later Associate Professor of Medicine, contributing to research, mentorship, and program development across multiple departments. She also held leadership roles at Beth Israel Deaconess Medical Center, including Director of Basic Cardiovascular Research and Faculty in Cardiovascular Medicine. Currently, she is the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine and the Executive Director at the Masonic Medical Research Institute (MMRI) in Utica, New York. At MMRI, she leads a team of over 60 researchers and staff, spearheads strategic initiatives, manages multimillion-dollar fundraising efforts, and drives national and international collaborations—making her a dynamic force in advancing cardiovascular and translational medicine.

🔬 Research Interests of Dr. Maria Kontaridis

Dr. Maria Kontaridis’s research is centered on unraveling the molecular mechanisms underlying cardiovascular diseases, congenital heart defects, and RASopathies—a group of genetic syndromes caused by mutations in the RAS-MAPK pathway. Her work explores signal transduction pathways, particularly focusing on protein phosphatases, kinases, and their role in cardiac development, function, and remodeling. She has a strong interest in translational medicine, aiming to bridge the gap between basic science and clinical application by identifying novel therapeutic targets for heart failure, arrhythmias, and vascular abnormalities. Through her leadership at the Masonic Medical Research Institute, she has expanded her research scope to include regenerative medicine, stem cell biology, and precision medicine approaches for complex cardiovascular disorders. Her interdisciplinary focus integrates molecular biology, genetics, and pharmacology to develop innovative strategies for diagnosis and treatment, with a goal of improving patient outcomes in both pediatric and adult populations.

🏅 Awards and Honors of Dr. Maria Kontaridis

Dr. Maria Kontaridis has received numerous prestigious awards and honors that recognize her scientific excellence, leadership, and contributions to biomedical research. One of her most distinguished accolades is the Doctor of Science, honoris causa (D.Sc. h.c.), awarded by SUNY Polytechnic Institute in 2025, reflecting her impact on science and public service. Throughout her career, she has been appointed to prominent academic and leadership positions, such as the Gordon K. Moe Professorship and Executive Director at the Masonic Medical Research Institute, affirming her influence in the field of cardiovascular medicine. She has also been invited to chair and organize major international symposia and scientific meetings, including the Sarnoff Cardiovascular Research Foundation Annual Meeting and the International RASopathies Symposium. Additionally, her recognition extends beyond academia into civic and economic development, where she serves on advisory and leadership boards, underlining her role as a visionary leader committed to advancing both science and society.

🏁 Conclusion

Dr. Maria Irene Kontaridis is highly suitable and deserving of the Best Researcher Award. Her career exemplifies excellence in academic leadership, global research collaboration, translational science, and mentorship. Her deep commitment to advancing cardiovascular medicine and biomedical innovation, combined with community involvement and advocacy for women in science, sets a benchmark for what this award represents.

📚 Publications Top Noted

Title: SHP2 happens, just sail with it: the role of the protein tyrosine phosphatase SHP2 in autoimmune and autoinflammatory diseases
Type: Review (Open Access)
Authors: Not listed in preview
Year: Not specified
Citations: 0
Title: Modulating the Secretome of Fat to Treat Heart Failure
Type: Review
Authors: Not listed in preview
Year: Not specified
Citations: 1
Title: Interorgan Crosstalk in Heart Failure and Cardiometabolic Diseases: A Compendium
Type: Review
Authors: Not listed in preview
Year: Not specified
Citations: 0
Title: RASopathies in Cardiac Disease
Type: Review (Open Access)
Authors: Not listed in preview
Year: Not specified
Citations: 0
Title: SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
Type: Research Article
Journal: Nature Communications
Authors: Not fully listed; Dr. Maria Kontaridis is one of them
Year: 2024
Citations: 6

Xiaodan Zhang | Medicine and Health Sciences | Best Researcher Award Medicine and Health Sciences

Published on 07/07/202510/07/2025 by Research Hypothesis

Assoc. Prof. Dr. Xiaodan Zhang | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences College of Life and Science Zhejiang Sci-Tech University, China

Dr. Xiaodan Zhang is an accomplished Associate Professor at the College of Life Science and Medicine, with a Ph.D. in Pharmacy from Chung-Ang University (2013). With over a decade of academic and research experience, she has made significant contributions to the fields of pharmacognosy, natural product chemistry, and metabolomics. Her research focuses on the spatial distribution and pharmacological properties of bioactive compounds using advanced techniques like UPLC-Q-TOF-MS and DESI-MSI. Dr. Zhang has published extensively in high-impact journals such as Horticulture Research, Food Chemistry, and Molecules, often serving as corresponding author. Her work is characterized by a strong interdisciplinary approach, combining omics technologies and mass spectrometry to uncover therapeutic potentials of traditional medicinal plants. Despite limited mention of major awards or grants, her consistent publication record, scientific rigor, and collaborative projects establish her as a highly credible and forward-thinking researcher in the biomedical sciences.

Professional Profile

Scopus Profile

🎓 Education Background of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang holds a distinguished academic background in the field of Pharmacy. She earned her Doctor of Philosophy (Ph.D.) in Pharmacy in 2013 from Chung-Ang University, South Korea—an institution recognized for its excellence in pharmaceutical sciences and biomedical research. Her doctoral studies laid the foundation for her future work in natural product pharmacology and metabolomics, equipping her with advanced knowledge in analytical chemistry, drug discovery, and plant-based therapeutic research. Her academic journey reflects a strong commitment to scientific inquiry and innovation.

💼 Professional Experience of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang has over a decade of dedicated academic and research experience in the biomedical sciences. She began her professional journey as an Assistant Professor at the College of Life Science and Medicine in 2013, a role she held for five years. In 2019, she was promoted to the position of Associate Professor, reflecting her growing leadership and contributions in research and teaching. Over these ten years, Dr. Zhang has been actively involved in advanced pharmacological studies, curriculum development, and interdisciplinary research collaborations. Her experience underscores a strong progression in academic ranks and a sustained commitment to excellence in the fields of pharmacy, life sciences, and medicinal chemistry.

🔬 Research Interests of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang’s research interests lie at the intersection of natural product pharmacology, metabolomics, and multi-omics integration. She is particularly focused on exploring the chemical composition, spatial distribution, and pharmacological activity of traditional medicinal plants using advanced analytical tools such as UPLC-Q-TOF-MS, DESI-MSI, and network pharmacology. Her work aims to identify bioactive compounds with anti-cancer, anti-inflammatory, antioxidant, and neuroprotective properties. By combining spectrum-effect relationships with high-resolution mass spectrometry, Dr. Zhang contributes to the scientific validation and modernization of herbal medicines. Her research not only advances fundamental knowledge in pharmaceutical sciences but also supports the development of safer and more effective therapeutic agents from natural sources.

🏅 Awards and Honors of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang has earned recognition for her dedicated contributions to the fields of pharmacy, metabolomics, and traditional medicine research. While specific awards and honors are not detailed in her current CV, her consistent authorship in high-impact journals such as Horticulture Research, Food Chemistry, and Molecules reflects a high level of academic distinction and peer recognition. Her role as a corresponding author on multiple publications and her advancement to Associate Professor further underscore the esteem she holds within the scientific community. As her research continues to gain traction globally, Dr. Zhang is well-positioned for future honors and prestigious research accolades in the biomedical and pharmaceutical sciences.

🏁 Conclusion

Dr. Xiaodan Zhang demonstrates strong suitability for the Best Researcher Award in Pharmacy or Life Sciences. Her profile reflects a high-caliber researcher with solid academic credentials, prolific publication output in impactful journals, and an evident commitment to advancing research in natural product pharmacology and metabolomics.

📚 Publications Top Note

Title: Alternaria alstroemeriae F1 inhibits Aspergillus flavus growth and weakens aflatoxins biosynthesis
Authors: [Not fully listed in your input]
Journal: Fungal Genetics and Biology
Year: 2025
Citations: 0
Title: Medicinal and edible homologous poly/oligo-saccharides: Structural features, effect on intestinal flora and preventing and treating type 2 diabetes, and their applications: A review
Authors: [Not fully listed in your input]
Type: Review Article
Year: 2025
Citations: 0
Title: Directed evolution of diacylglycerol acyltransferases 2 promotes lipids and triglyceride accumulation
Authors: [Not fully listed in your input]
Journal: Plant Molecular Biology
Year: 2025
Citations: 0
Title: Exploring the Metabolic and Transcriptomic Profiles of Tetrastigma hemsleyanum for Tissue-Specific Compound Accumulation
Authors: [Not fully listed in your input]
Journal: Frontiers in Plant Science
Year: 2025
Open Access:
Citations: 0
Title: Analysis of the correlation between the distribution of microorganisms carried by Coix seed and fungal toxins, and the biological control of aflatoxin
Authors: [Not fully listed in your input]
Journal: Current Research in Food Science
Year: 2025
Open Access:
Citations: 0

Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Published on 20/06/202520/06/2025 by Research Hypothesis

Prof. Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Distinguished Chair Professor at National Tsing Hua University, Taiwan

Professor Reuben Jih-Ru Hwu is a Distinguished Chair Professor Emeritus with Lifetime Honor at National Tsing Hua University, Taiwan, and a globally recognized chemist whose career spans over four decades of pioneering research and academic excellence. Earning his Ph.D. from Stanford University in 1982, he served as a faculty member at Johns Hopkins University before returning to Asia, where he built an outstanding interdisciplinary research portfolio in drug design, DNA-cleaving agents, nano-biomaterials, organosilicon chemistry, natural product synthesis, and green chemistry. With over 253 publications and 52 patents, his contributions reflect both scientific rigor and practical innovation. Professor Hwu has been honored with numerous prestigious awards, including the TWAS Award, the Chinese American Chemical Society’s Outstanding Achievement Award, and the Taiwan National Chair Professorship. He is a Fellow of esteemed organizations such as TWAS, IUPAC, the Royal Society of Chemistry, and the European Academy of Sciences and Arts. His leadership roles, including presidencies of major chemical societies such as FACS and the Asian Federation for Medicinal Chemistry, further underscore his influential presence in the global scientific community.

Professional Profile

🎓 Education of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu began his academic journey with a strong foundation in chemistry, culminating in a Ph.D. in Chemistry from the prestigious Stanford University in 1982. His doctoral training at Stanford equipped him with cutting-edge expertise in chemical research, setting the stage for his impactful scientific career. Prior to that, he demonstrated exceptional academic promise, which was later recognized through multiple international awards and fellowships. His educational background reflects both academic excellence and a commitment to innovation, shaping him into a global leader in multidisciplinary chemical sciences.

💼 Professional Experience of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has had a distinguished professional career marked by academic leadership, research excellence, and international collaboration. After earning his Ph.D. from Stanford University in 1982, he began his academic tenure as a faculty member at Johns Hopkins University, where he served from 1982 to 1991. He later returned to Taiwan and became a Distinguished Chair Professor at National Tsing Hua University, where he was eventually honored as Professor Emeritus with Lifetime Honor. Throughout his career, Professor Hwu has led groundbreaking research across diverse areas such as medicinal chemistry, nano-biomaterials, green chemistry, and synthetic methodology. He has also held key leadership roles in international scientific organizations, including serving as President of the Chinese American Chemical Society, the Asian Federation for Medicinal Chemistry, and the Federation of Asian Chemical Societies, demonstrating his global impact and commitment to advancing chemical sciences worldwide.

🔬 Research Interests of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu’s research interests span a broad and impactful spectrum of chemical sciences, reflecting his passion for innovation and interdisciplinary exploration. His work encompasses drug design and synthesis, the development of DNA-cleaving agents, and the creation of advanced nano-biomaterials for biomedical applications. He has made significant contributions to natural product synthesis, organosilicon chemistry, and the discovery of novel chemical reactions and reagents. In recent years, Professor Hwu has also focused on sustainability and green chemistry, aiming to develop eco-friendly chemical processes. His diverse and forward-looking research not only advances scientific knowledge but also addresses critical global challenges in health, environment, and technology.

🏅 Awards and Honors of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has received numerous prestigious awards and honors that reflect his outstanding contributions to the chemical sciences. Notable recognitions include the 2023 Outstanding Achievement Award from the Chinese American Chemical Society, the Gulf Chemistry Association Trophy (2022), and the CAS Registry Innovator Award (2022). He has also been honored with the Taiwan National Chair Professorship, the TWAS Award (1997), and was named one of the JCI Ten Outstanding Young Persons of the World (1994). Earlier in his career, he received the FACS Distinguished Young Chemist Award (1992–93), the Alfred P. Sloan Research Fellowship (1986–1990), and the Stuart Pharmaceuticals Achievement Award (1986). His accolades span decades and continents, highlighting his influence in both academic and applied chemistry. These awards are a testament to his innovation, leadership, and lifelong dedication to advancing science.

✅Conclusion

Professor Reuben Jih-Ru Hwu is a highly qualified and exceptional candidate for the Best Researcher Award. His prolific academic output, international recognitions, scientific leadership, and broad research contributions place him among the top-tier scientists in the field of chemistry and interdisciplinary sciences. With slight enhancement in showcasing his recent impactful contributions and societal influence, his nomination would not only be justified but compelling on a global scale.

📚 Publications

1. Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael Addition

Title: Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael AdditionAuthors: Jih Ru Hwu, Khagendra Prasad Bohara, Mohit Kapoor, et al. (with collaborators from National Tsing Hua University and affiliated institutes)
Journal: Journal of Organic Chemistry
Year: 2025 (published ~2 months ago from June 2025)
Citations: 0

2. 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents

Title: 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents
Authors: Shu‑Yu Lin, Wen‑Chieh Huang, Shwu‑Chen Tsay, Johan Neyts, Pieter Leyssen, Chun‑Cheng Lin, Kuo Chu Hwang, Jia‑Cherng Horng, and Jih Ru Hwu
Journal: Molecules (Open access)
Year: 2025 (Volume 30, Issue 8, Article 1776)
Citations: 0

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Published on 07/05/202507/05/2025 by Research Hypothesis

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.
3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.
“Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.
“Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.
“Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.
“Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.
“Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.
“Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.
“Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Published on 24/02/202524/02/2025 by Research Hypothesis

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Dr GORDON WEST, Pacific Lutheran University School of Nursing – Tacoma, WA, United States

Dr. Gordon West is a dedicated nurse scientist and healthcare leader with a PhD from the Uniformed Services University (2016) 🎓. He holds an MHA from Baylor University (2006) and a BSN from McMurry University (1998) 🏥. Currently, he is a Research Nurse at The Geneva Foundation-Madigan and an Assistant Professor at Pacific Lutheran University 📚. With vast experience in military and civilian healthcare, he has led numerous research projects on infection control, patient safety, and military health 🩺. A Fellow of the American College of Healthcare Executives, he has received multiple awards for nursing research and excellence 🏆.

Publication Profile

Google Scholar

Education

Dr. Gordon West 🎓 is a dedicated healthcare professional with a strong academic background. He earned his Ph.D. in 2016 from the Uniformed Services University of the Health Sciences 🏥 in Bethesda, MD. Prior to that, he completed his Master of Healthcare Administration (MHA) in 2006 at Baylor University 🏛️ in Fort Sam Houston. His journey in healthcare began with a Bachelor of Science in Nursing (BSN) from McMurry University 🎓 in Abilene, TX, in 1998. With extensive education and expertise, Dr. West continues to contribute to the field of healthcare and administration with passion and dedication. 💉📚

Experience

Dr. Gordon West is a dedicated Research Nurse 🩺 at The Geneva Foundation – Madigan (2023-present) and an Assistant Professor 📚 at Pacific Lutheran University (2022-present). He actively contributes as a Research Board Member at the Washington State Nursing Association & Health Care Council and a Board Member at Rainer Olympic Nurses Association. His extensive military nursing career includes leadership roles at Madigan AMC, Tripler, and Fort Belvoir 🏥, alongside international service in Korea 🇰🇷 and Iraq 🇮🇶. A Ph.D. graduate from USUHS 🎓, he also teaches at Maryville University and Central Michigan University, shaping future nursing professionals. 🌟

Awards & Honors

Dr. Gordon West has been recognized for his outstanding contributions to nursing and healthcare research 🏥📚. In 2023, he received a Daisy Nomination from Pacific Lutheran University for his dedication to patient care and nursing excellence 🌿🏆. In 2019, he was honored with the ANCA Nursing Research Award by the Army Nurse Corps Association, highlighting his impactful research in military nursing 🎖️🔬. That same year, he also received the Excellence in Nursing Research Award from the Defense Health Agency, acknowledging his commitment to advancing healthcare through evidence-based practices and innovation 🏅💡.

Research Focus

Dr. Gordon B. West’s research explores critical language pedagogy 🎓📖, focusing on morality, identity, and power in neoliberal English language education 🌍💬. His work critically examines good teacher identities in South Korea 🇰🇷, the politicization of language educators 🗣️⚖️, and the emotional complexities of critical pedagogy ❤️🧠. He also investigates sociohistorical perspectives on literacy 📚⏳ and the challenges of critical practitioner research under difficult conditions 🔍🛠️. Through qualitative and materialist approaches, Dr. West sheds light on language education as both a tool for liberation and oppression ✊🔗, emphasizing the impact of neoliberalism on English teaching 💵🏫.

Presentation

Dr. Gordon West is a dedicated nursing researcher focusing on infection control 🦠, patient safety 🏥, and healthcare communication 📢. He has presented extensively, including at the Phyllis J. Verhonick Conference (2016) on patient education and fall prevention 🩺. His work on bacterial contamination of hospital uniforms led to multiple presentations at the American Organization of Nurse Executives Conference (2016-2017) and the Sigma 29th International Nursing Research Conference in Melbourne (2018) 🌏. He also explored hands-free communication in nursing at TSNRP (2017). His research enhances clinical safety, infection prevention, and nurse satisfaction, shaping better healthcare practices globally 🌍.

Publication Top Notes

Navigating morality in neoliberal spaces of English language education

Young learners’ portrayals of ‘good English teacher’identities in South Korea

Critical practitioner research in language education under difficult circumstances

“How did you become political?”: Narratives of junior researcher-practitioners in applied linguistics

“Is this a safe space?”: Examining an emotionally charged eruption in critical language pedagogy

Literacy is a Sociohistoric Phenomenon with the Potential to Liberate and Oppress

Doing critical language pedagogy in neoliberal spaces: A materialist narrative analysis of teaching young learners of English in a Korean hagwon

Positioning of female marriage immigrants in South Korea: a multimodal textbook analysis

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Published on 18/06/202418/06/2024 by Research Hypothesis

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Dr Muritala Suleiman Odidi, Federal University Dutse Jigawa State, Nigeria

Dr. Muritala Suleiman Odidi is a dedicated lecturer at Kogi State University, Anyigba, Nigeria, specializing in gross anatomy, embryology, genetics, biostatistics, and anthropology since June 2018 📚. He uses audio-visual microscopy to enhance histology teaching 🧬. Before academia, he was a Business Development Executive at Emzor Pharmaceutical Industries (2015-2018) and a Senior Medical Sales Representative at Nosak Health Care Limited (2012-2015) 💊. He has attended numerous workshops and conferences globally, contributed to many publications, and holds several administrative roles within his department 🏅. His research focuses on forensic science and anthropometry 🔬.

Publication profile

google scholar

Education

He hold a PhD in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, conferred on December 16th, 2022 🎓. Prior to this, He completed my MSc in Human Anatomy and Physical Anthropology at Bayero University, Kano, Nigeria, on March 30th, 2016 📚. My academic journey began with a BSc in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, where I graduated with a second class upper on April 16th, 2009 🎓. This robust educational foundation has equipped me with extensive knowledge and expertise in the field of human anatomy and physical anthropology 🧠.

Experience

Since June 2018, he have been a lecturer, teaching and demonstrating gross anatomy, embryology, genetics, biostatistics, and anthropology to undergraduate medical students. Additionally, he utilize audio-visual microscopy to effectively teach histology 📚. Previously, from March 2015 to June 2018, he worked as a Business Development Executive at Emzor Pharmaceutical Industries Limited in Lagos, Nigeria. In this role, he organized and conducted Continuing Medical Education on the company’s product ranges, brokered business deals with health institutions, and interfaced with Key Opinion Leaders (KOL) 💼. Prior to that, from February 2012 to February 2015, I served as a Senior Medical Sales Representative at Nosak Health Care Limited, where he promoted new products and increased brand awareness during community pharmacist meetings and conferences 🌟.

Awards

He was honored to serve as a Fellow in the Data Science Fellowship Program by the Bureau of Statistics, Kaduna State Government, in collaboration with the Bill and Melinda Gates Foundation (BMGF) from January to July 2021 📊. During this enriching experience, he honed my data science skills and contributed to impactful projects 🎯. Additionally, he received a prestigious prize and Certificate of Honour for meritorious services from the Government of Oyo State of Nigeria, in collaboration with the National Youth Service Corps 🏅. This recognition underscores my dedication and hard work in service to my community and nation 🌟.

Research focus

Based on the provided publication list, M.O. Suleiman’s research focus spans multiple disciplines including forensic science, entomology, anatomy, and toxicology. Their work covers the use of plant-based substances for pest control, the effects of plant extracts on health, and various aspects of human morphology and forensic analysis. This diversity indicates a multidisciplinary approach with significant contributions to both environmental and health sciences.